Not yet recruiting
Rheumatoid arthritis
Not yet recruitingOptimizing biologic tapering in patients with rheumatoid arthritis using tocilizumab, drug combination, and olfactory placebo conditioning
Registered drug
Optimizing biologic tapering in patients with rheumatoid arthritis using tocilizumab, drug combination, and olfactory placebo conditioning
Registered drug
- Disease:Rheumatoid arthritis
- Substances:AbataceptAdalimumab+5
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Abatacept
- Sponsor:Universiteit Leiden
